CD44
From Wikipedia, the free encyclopedia
(Redirected from CSPG8)
| edit |
| CD44 molecule (Indian blood group) | |||||
|---|---|---|---|---|---|
 PDB rendering based on 1poz. | |||||
| |||||
| Identifiers | |||||
| Symbols | CD44; CDW44; CSPG8; ECMR-III; HCELL; IN; LHR; MC56; MDU2; MDU3; MGC10468; MIC4; MUTCH-I; Pgp1 | ||||
| External IDs | OMIM: 107269 MGI: 88338 HomoloGene: 508 GeneCards: CD44 Gene | ||||
| |||||
| RNA expression pattern | |||||
 | |||||
 | |||||
 | |||||
| More reference expression data | |||||
| Orthologs | |||||
| Species | Human | Mouse | |||
| Entrez | 960 | 12505 | |||
| Ensembl | ENSG00000026508 | ENSMUSG00000005087 | |||
| UniProt | P16070 | P15379 | |||
| RefSeq (mRNA) | NM_000610 | NM_001039150 | |||
| RefSeq (protein) | NP_000601 | NP_001034239 | |||
| Location (UCSC) | Chr 11: 35.12 - 35.21 Mb | Chr 2: 102.61 - 102.7 Mb | |||
| PubMed search | [1] | [2] | |||
Contents[hide] |
Tissue distribution and isoforms
CD44 is expressed in a large number of mammalian cell types. The standard isoform, designated CD44s, comprising exons 1–5 and 16–20 is expressed in most cell types. CD44 splice variants containing variable exons are designated CD44v. Some epithelial cells also express a larger isoform (CD44E), which includes exons v8–10.[2]Function
CD44 is a receptor for hyaluronic acid and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). CD44 function is controlled by its posttranslational modifications. One critical modification involves discrete sialofucosylations rendering the selectin-binding glycoform of CD44 called HCELL (for Hematopoietic Cell E-selectin/L-selectin Ligand). The HCELL glycoform was originally discovered on human hematopoietic stem cells and leukemic blasts,[3][4][5][6] and was subsequently identified on cancer cells.[7][8][9][10][11] HCELL functions as a "bone homing receptor", directing migration of human hematopoietic stem cells and mesenchymal stem cells to bone marrow.[5] Ex vivo glycan engineering of the surface of live cells has been used to enforce HCELL expression on any cell that expresses CD44.[12] CD44 glycosylation also directly controls its binding capacity to fibrin and immobilized fibrinogen.[13][14]This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. Splice variants of CD44 on colon cancer cells display sialofucosylated HCELL glycoforms that serve as P-, L-, and E-selectin ligands and fibrin, but not fibrinogen, receptors under hemodynamic flow conditions pertinent to the process of cancer metastasis. CD44 gene transcription is at least in part activated by beta-catenin and Wnt signalling (also linked to tumour development).
Clinical significance
The protein is a determinant for the Indian blood group system. ISBT 023- CD44 expression is an indicative marker for effector-memory T-cells. Memory cell proliferation (activation) can also be assayed in vitro with CFSE chemical tagging.
Endometrial cells in women with endometriosis demonstrate increased expression of splice variants of CD44, and increased adherence to peritoneal cells.[17]
CD44 variant isoforms are also relevant to the progression of head and neck squamous cell carcinoma.[18][19]
Monoclonal antibodies against CD44 variants include bivatuzumab for v6.
